BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 18197961)

  • 1. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites.
    Umgelter A; Reindl W; Franzen M; Lenhardt C; Huber W; Schmid RM
    Intensive Care Med; 2009 Jan; 35(1):152-6. PubMed ID: 18802688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1.
    Umgelter A; Wagner KS; Reindl W; Luppa PB; Geisler F; Huber W; Schmid RM
    Ann Hepatol; 2012; 11(2):232-9. PubMed ID: 22345341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.
    Mookerjee RP; Jalan R
    Crit Care; 2008; 12(2):119. PubMed ID: 18394181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
    Schneditz D; Bachler I; Stadlbauer V; Stauber RE
    Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.
    Umgelter A; Wagner K; Reindl W; Nurtsch N; Huber W; Schmid RM
    BMC Gastroenterol; 2008 Aug; 8():39. PubMed ID: 18752670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
    Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
    Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study.
    Péron JM; Bureau C; Gonzalez L; Garcia-Ricard F; de Soyres O; Dupuis E; Alric L; Pourrat J; Vinel JP
    Am J Gastroenterol; 2005 Dec; 100(12):2702-7. PubMed ID: 16393223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.